Carlos Garcia, MD
MOHS-Micrographic Surgery · Oklahoma City, OKNPI 1013985217
Payments from drug & device makers
Across 676 payments — averaging $21.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Lilly USA, LLC$2K
- Sanofi$2K
- Johnson & Johnson$1K
- Novartis$1K
- UCB, Inc.$1K
- plus $5K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 105 | $2,129 |
| Lilly USA, LLC | 103 | $1,937 |
| Sanofi | 50 | $1,614 |
| Johnson & Johnson | 44 | $1,336 |
| Novartis | 72 | $1,219 |
| UCB, Inc. | 53 | $1,003 |
| Regeneron Healthcare Solutions, Inc. | 30 | $892 |
| Pfizer | 44 | $873 |
| LEO Pharma Inc. | 47 | $716 |
| Sun Pharmaceutical Industries Inc. | 23 | $480 |
| E.r. Squibb & Sons, L.L.C. | 17 | $416 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $311 |
| Amgen | 12 | $204 |
| Galderma Laboratories, L.p. | 13 | $194 |
| Arcutis Biotherapeutics, Inc. | 16 | $155 |
| Helsinn Therapeutics (U.S.), Inc. | 4 | $148 |
| Mayne Pharma Commercial LLC | 4 | $131 |
| Dermira, Inc. | 1 | $122 |
| Janssen Scientific Affairs, LLC | 1 | $91 |
| Boehringer Ingelheim | 5 | $83 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Incyte Corporation | 5 | $79 |
| Genentech USA, Inc. | 6 | $76 |
| Nabriva Therapeutics, PLC | 3 | $46 |
| VYNE Pharmaceuticals Inc. | 2 | $38 |
| Merck | 2 | $22 |
| Organon | 5 | $18 |
| DUSA Pharmaceuticals, Inc. | 1 | $18 |
| Krystal Biotech Inc | 1 | $14 |
How this compares
Too few mohs-micrographic surgery providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other mohs-micrographic surgery in Oklahoma City
- Travis BlalockOklahoma City$13K
- Jason HirshburgOklahoma City$1K
- Todd MolletOklahoma City$808
- James StewartOklahoma City$784
- Brandon RhinehartOklahoma City$620
- Mary Christian ReedTulsa$13K
- Robert FischerTulsa$11K
- Carlos Gomez-MeadeBroken Arrow$2K
- Edward YobTulsa$380
- Scott MeyersTulsa$307
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.